Sanofi: CHMP recommends approval of Cablivi(TM) (caplacizumab)
Go back to Sanofi: CHMP recommends approval of Cablivi(TM) (caplacizumab)| BANCO SANTANDER S.A. (NYSE: SAN) | Delayed: 14.82 +0.19 (1.30%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.63 | 52 Week High | $5.58 | |||
| Open | $14.90 | 52 Week Low | $3.60 | |||
| Day High | $14.92 | P/E | N/A | |||
| Day Low | $14.79 | EPS | $0.00 | |||
| Volume | 2,275,313 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 42.62 -0.1 (0.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.72 | 52 Week High | $44.76 | |||
| Open | $42.81 | 52 Week Low | $36.81 | |||
| Day High | $42.89 | P/E | N/A | |||
| Day Low | $42.46 | EPS | $0.00 | |||
| Volume | 413,864 | |||||
